Drug General Information |
Drug ID |
D0A9OV
|
Former ID |
DCL000347
|
Drug Name |
TAK165
|
Synonyms |
Mubritinib; TAK 165; Mubritinib (USAN/INN); 4-[[4-[4-(triazol-1-yl)butyl]phenoxy]methyl]-2-[(E)-2-[4-(trifluoromethyl)phenyl]ethenyl]-1,3-oxazole
|
Drug Type |
Small molecular drug
|
Therapeutic Class |
Anticancer Agents
|
Company |
Takeda Pharmaceuticals
|
Structure |
|
Download
2D MOL
3D MOL
|
Formula |
C25H23F3N4O2
|
InChI |
InChI=1S/C25H23F3N4O2/c26-25(27,28)21-9-4-20(5-10-21)8-13-24-30-22(18-34-24)17-33-23-11-6-19(7-12-23)3-1-2-15-32-16-14-29-31-32/h4-14,16,18H,1-3,15,17H2/b13-8+
|
InChIKey |
ZTFBIUXIQYRUNT-MDWZMJQESA-N
|
CAS Number |
CAS 366017-09-6
|
PubChem Compound ID |
|
PubChem Substance ID |
11969389, 14760763, 17398009, 43037052, 50490680, 57369821, 92721420, 99299526, 114571134, 123122738, 124360689, 124757654, 125164458, 126619164, 126661686, 131312231, 135178532, 135698690, 136348757, 136349478, 136367609, 137124306, 143157306, 144115322, 152057420, 152344431, 160682577, 162011934, 162037824, 162202684, 178102633, 179150389, 179322939, 186009055, 198947389, 204359629, 223396725, 223668772, 223704690, 223786982, 226472299, 241073514, 252157389, 252160688, 252215852, 252451421, 252543383
|
Target and Pathway |
References |